Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Schulz

Showing results (21-30 of 55) with videos related to

Pageof 6
Sort By:
World Journal of Gastroenterology|October 28, 2009
UGT1A1 gene polymorphism: impact on toxicity and efficacy of irinotecan-based regimens in metastatic colorectal cancerChristoph Schulz, Volker Heinemann, Andreas Schalhorn, et al.
Journal of Cellular Physiology|April 6, 2011
Dynamic redistribution of calcium sensitive potassium channels (hK(Ca)3.1) in migrating cellsAlbrecht Schwab, Volodymyr Nechyporuk-Zloy, Birgit Gassner, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 20, 2008
Gilbert's Syndrome and irinotecan toxicity: combination with UDP-glucuronosyltransferase 1A7 variants increases riskTim O Lankisch, Christoph Schulz, Thomas Zwingers, et al.
Acta Oncologica (Stockholm, Sweden)|December 19, 2012
Early tumor shrinkage in patients with metastatic colorectal cancer receiving first-line treatment with cetuximab combined with either CAPIRI or CAPOX: an analysis of the German AIO KRK 0104 trialDominik P Modest, Ruediger P Laubender, Sebastian Stintzing, et al.
Anticancer Research|December 26, 2012
Glucose and lipid metabolism in patients with advanced pancreatic cancer receiving palliative chemotherapyKatharina Zeiss, Klaus G Parhofer, Volker Heinemann, et al.
The Journal of Prosthetic Dentistry|March 5, 2003
Comparison of microleakage on one composite etched with phosphoric acid or a combination of phosphoric and hydrofluoric acids and bonded with several different systemsSusanne Szep, Nicole Langner, Silja Bayer, et al.
Acta Oncologica (Stockholm, Sweden)|July 15, 2014
Surrogate endpoints in second-line treatment for mCRC: a systematic literature-based analysis from 23 randomised trialsClemens Giessen, Ruediger Paul Laubender, Donna Pauler Ankerst, et al.
Visceral Medicine|June 15, 2017
Pattern and Dynamics of Distant Metastases in Metastatic Colorectal CancerJulian Walter Holch, Maximilian Demmer, Charlotte Lamersdorf, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 17, 2014
Evaluation of preoperative serum markers for individual patient prognosis in stage I-III rectal cancerClemens Giessen, Dorothea Nagel, Maria Glas, et al.
Oncology Research and Treatment|August 17, 2018
Extracorporeal Membrane Oxygenation in Predominantly Leuco- and Thrombocytopenic Haematologic/Oncologic Patients with Acute Respiratory Distress Syndrome - a Single-Centre ExperienceStephanie-Susanne Stecher, Georg Beyer, Elisabetta Goni, et al.
Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
World Journal of Gastroenterology|October 28, 2009
UGT1A1 gene polymorphism: impact on toxicity and efficacy of irinotecan-based regimens in metastatic colorectal cancerChristoph Schulz, Volker Heinemann, Andreas Schalhorn, et al.
Journal of Cellular Physiology|April 6, 2011
Dynamic redistribution of calcium sensitive potassium channels (hK(Ca)3.1) in migrating cellsAlbrecht Schwab, Volodymyr Nechyporuk-Zloy, Birgit Gassner, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 20, 2008
Gilbert's Syndrome and irinotecan toxicity: combination with UDP-glucuronosyltransferase 1A7 variants increases riskTim O Lankisch, Christoph Schulz, Thomas Zwingers, et al.
Acta Oncologica (Stockholm, Sweden)|December 19, 2012
Early tumor shrinkage in patients with metastatic colorectal cancer receiving first-line treatment with cetuximab combined with either CAPIRI or CAPOX: an analysis of the German AIO KRK 0104 trialDominik P Modest, Ruediger P Laubender, Sebastian Stintzing, et al.
Anticancer Research|December 26, 2012
Glucose and lipid metabolism in patients with advanced pancreatic cancer receiving palliative chemotherapyKatharina Zeiss, Klaus G Parhofer, Volker Heinemann, et al.
The Journal of Prosthetic Dentistry|March 5, 2003
Comparison of microleakage on one composite etched with phosphoric acid or a combination of phosphoric and hydrofluoric acids and bonded with several different systemsSusanne Szep, Nicole Langner, Silja Bayer, et al.
Acta Oncologica (Stockholm, Sweden)|July 15, 2014
Surrogate endpoints in second-line treatment for mCRC: a systematic literature-based analysis from 23 randomised trialsClemens Giessen, Ruediger Paul Laubender, Donna Pauler Ankerst, et al.
Visceral Medicine|June 15, 2017
Pattern and Dynamics of Distant Metastases in Metastatic Colorectal CancerJulian Walter Holch, Maximilian Demmer, Charlotte Lamersdorf, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 17, 2014
Evaluation of preoperative serum markers for individual patient prognosis in stage I-III rectal cancerClemens Giessen, Dorothea Nagel, Maria Glas, et al.
Oncology Research and Treatment|August 17, 2018
Extracorporeal Membrane Oxygenation in Predominantly Leuco- and Thrombocytopenic Haematologic/Oncologic Patients with Acute Respiratory Distress Syndrome - a Single-Centre ExperienceStephanie-Susanne Stecher, Georg Beyer, Elisabetta Goni, et al.
Pageof 6